Elevated fasting insulin, visceral adiposity, non-alcoholic fatty liver disease, and chronic systemic inflammation are not merely cardiovascular or endocrine risk factors they represent a hostile cellular environment in which neoplastic transformation is more likely to occur, progress, and evade immune surveillance
In annual filings to state regulators for plan year 2025, some insurers cited increases in utilization of GLP-1 drugs as a contributor to rising premiums
Because Dr Spencer manages both areas herself, many patients address hormonal and skin concerns together, though treatments themselves are booked separately.
Semaglutide GLP-1 vs Ozempic vs Wegovy vs Mounjaro: Whats the Difference
It may mean the pace of escalation is too aggressive, the patients nutrition is not keeping up, or constipation and hydration need to be addressed first
Cited in: Why Some People Lose Their Hair When They're On GLP-1s